Sunday, 25 March 2018

CSIR-IGIB to commercialise its genetic tests

10 March 2018 | News

The institute has entered into an agreement with Dr Lal PathLabs for licensing the genetic tests.

Image credit-

Image credit-

The Council of Scientific and Industrial Research’s Delhi-based Institute of Genomics & Integrative Biology (CSIR-IGIB) has decided to commercialise a set of 27 genetics tests it has developed over the years.

The institute has entered into an agreement with Dr Lal PathLabs, which has a large network of diagnostic centres across the country, for licensing the genetic tests. These tests are expected to be launched in phases over the year.

With its rich expertise in the area of genomics and a wide network of clinical partners across the country, IGIB has also embarked on a unique outreach programme. Called GOMED (Genomics and other Omics technologies for Enabling Medical Decision), the programme provides a platform for clinicians to tap into the rich and varied expertise of CSIR-IGIB in disease genomics to solve clinical problems.

The project is funded through the Fast-Track Translation (FTT) Research Programme of CSIR.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Has the medical fraternity lost its ethics completely?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls